nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer

Oncotarget

Volumn 5, Issue 11, 2014, Pages 3944-3955

  Lee, Kwang Soo ^a,b   Park, Jong Lyul ^c,d   Lee, Kwanbok ^a   Richardson, Lauren E ^a,e   Johnson, Betty H ^a   Lee, Hyun Sung ^f   Lee, Ju Seog ^f   Kim, Sang Bae ^f   Kwon, Oh Hyung ^c   Song, Kyu Sang ^g   Kim, Yong Sung ^c,d   Ashktorab, Hassan ^h   Smoot, Duane T ^h   Jeon, Sung Ho ^b   Kim, Seon Young ^c,d   Lee, Yong Sun ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Hallym University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d University of Science and Technology (UST)   (South Korea)

^e LAMAR UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g Chungnam National University   (South Korea)

^h HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cell proliferation; CpG DNA methylation; Gastric cancer; nc886; Tumor suppressor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LONG UNTRANSLATED RNA; PROTEIN FOS; PROTEIN NC886; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CANCER SURVIVAL; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FOS GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NF KAPPA B GENE; ONCOGENE MYC; PROMOTER REGION; STOMACH CANCER; STOMACH CARCINOGENESIS; CELL GROWTH; GENETIC TRANSFECTION; GENETICS; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

CELL GROWTH PROCESSES; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; HUMANS; RNA, UNTRANSLATED; STOMACH NEOPLASMS; TRANSFECTION;

EID: 84903542256     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2047     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90.
2. Lee K, Kunkeaw N, Jeon SH, Lee I, Johnson BH, Kang GY, Bang JY, Park HS, Leelayuwat C and Lee YS. Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. RNA. 2011; 17(6):1076-1089.
3. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM and Rowley JD. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986; 4(3):325-345.
4. Fairman J, Chumakov I, Chinault AC, Nowell PC and Nagarajan L. Physical mapping of the minimal region of loss in 5q-chromosome. Proc Natl Acad Sci U S A. 1995; 92(16):7406-7410.
5. Kunkeaw N, Jeon SH, Lee K, Johnson BH, Tanasanvimon S, Javle M, Pairojkul C, Chamgramol Y, Wongfieng W, Gong B, Leelayuwat C and Lee YS. Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene. 2013; 32(32):3722-3731.
6. Treppendahl MB, Qiu X, Sogaard A, Yang X, Nandrup-Bus C, Hother C, Andersen MK, Kjeldsen L, Mollgard L, Hellstrom-Lindberg E, Jendholm J, Porse BT, Jones PA, Liang G and Gronbaek K. Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML. Blood. 2012; 119(1):206-216.
7. Oler AJ, Alla RK, Roberts DN, Wong A, Hollenhorst PC, Chandler KJ, Cassiday PA, Nelson CA, Hagedorn CH, Graves BJ and Cairns BR. Human RNA polymerase III transcriptomes and relationships to Pol II promoter chromatin and enhancer-binding factors. Nat Struct Mol Biol. 2010; 17(5):620-628.
8. Canella D, Praz V, Reina JH, Cousin P and Hernandez N. Defining the RNA polymerase III transcriptome: Genomewide localization of the RNA polymerase III transcription machinery in human cells. Genome Res. 2010; 20(6):710-721.
9. Marshall L and White RJ. Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer. 2008; 8(12):911-914.
10. Jeon SH, Lee K, Lee KS, Kunkeaw N, Johnson BH, Holthauzen LM, Gong B, Leelayuwat C and Lee YS. Characterization of the direct physical interaction of nc886, a cellular non-coding RNA, and PKR. FEBS Lett. 2012; 586(19):3477-3484.
11. Jeon SH, Johnson BH and Lee YS. A tumor surveillance model: a non-coding RNA senses neoplastic cells and its protein partner signals cell death. Int J Mol Sci. 2012; 13(10):13134-13139.
12. Heyn H and Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet. 2012; 13(10):679-692.
13. Besser D, Gotz F, Schulze-Forster K, Wagner H, Kroger H and Simon D. DNA methylation inhibits transcription by RNA polymerase III of a tRNA gene, but not of a 5S rRNA gene. FEBS Lett. 1990; 269(2):358-362.
14. Banati F, Koroknai A, Salamon D, Takacs M, Minarovits-Kormuta S, Wolf H, Niller HH and Minarovits J. CpGmethylation silences the activity of the RNA polymerase III transcribed EBER-1 promoter of Epstein-Barr virus. FEBS Lett. 2008; 582(5):705-709.
15. Selvakumar T, Gjidoda A, Hovde SL and Henry RW. Regulation of human RNA polymerase III transcription by DNMT1 and DNMT3a DNA methyltransferases. J Biol Chem. 2012; 287(10):7039-7050.
16. Marlink KL, Bacon KD, Sheppard BC, Ashktorab H, Smoot DT, Cover TL, Deveney CW and Rutten MJ. Effects of Helicobacter pylori on intracellular Ca2+ signaling in normal human gastric mucous epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2003; 285(1):G163-176.
17. Takai D and Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A. 2002; 99(6):3740-3745.
18. Gardiner-Garden M and Frommer M. CpG islands in vertebrate genomes. J Mol Biol. 1987; 196(2):261-282.
19. Xiong Y, Zhang L, Holloway AK, Wu X, Su L and Kebebew E. MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer. PLoS One. 2011; 6(10):e24717.
20. Cao J, Song Y, Bi N, Shen J, Liu W, Fan J, Sun G, Tong T, He J, Shi Y, Zhang X, Lu N, He Y, Zhang H, Ma K, Luo X, et al. DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer. Cancer Res. 2013; 73(11):3326-3335.
21. Nordentoft I, Birkenkamp-Demtroder K, Agerbaek M, Theodorescu D, Ostenfeld MS, Hartmann A, Borre M, Orntoft TF and Dyrskjot L. miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer. BMC Med Genomics. 2012; 5:40.
22. Miller AD, Curran T and Verma IM. c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell. 1984; 36(1):51-60.
23. Gao W, Shen H, Liu L, Xu J and Shu Y. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol. 2011; 137(4):557-566.
24. Xiao W, Bao ZX, Zhang CY, Zhang XY, Shi LJ, Zhou ZT and Jiang WW. Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia. PLoS One. 2012; 7(6):e38648.
25. Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K, Lim MS, Piva R, Barreca A, Pellegrino E, Spaccarotella E, Lachel CM, Kucuk C, Jiang CS, Hu X, Bhagavathi S, et al. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood. 2013; 122(12):2083-2092.
26. Li JH, Xiao X, Zhang YN, Wang YM, Feng LM, Wu YM and Zhang YX. MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. Gynecol Oncol. 2011; 120(1):145-151.
27. Han ZB, Zhong L, Teng MJ, Fan JW, Tang HM, Wu JY, Chen HY, Wang ZW, Qiu GQ and Peng ZH. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. Mol Oncol. 2012; 6(4):445-457.
28. Pillai MM, Yang X, Balakrishnan I, Bemis L and Torok-Storb B. MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells. PLoS One. 2010; 5(12):e14304.
29. Asaoka T, Sotolongo B, Island ER, Tryphonopoulos P, Selvaggi G, Moon J, Tekin A, Amador A, Levi DM, Garcia J, Smith L, Nishida S, Weppler D, Tzakis AG and Ruiz P. MicroRNA signature of intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies. Am J Transplant. 2012; 12(2):458-468.
30. Yu XF, Zou J, Bao ZJ and Dong J. miR-93 suppresses proliferation and colony formation of human colon cancer stem cells. World J Gastroenterol. 2011; 17(42):4711-4717.
31. Mahishi LH, Hart RP, Lynch DR and Ratan RR. miR-886-3p levels are elevated in Friedreich ataxia. J Neurosci. 2012; 32(27):9369-9373.
32. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ and Guegler KJ. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005; 33(20):e179.
33. Kim SY and Volsky DJ. PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics. 2005; 6:144.
34. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES and Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-15550.